Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma

被引:39
作者
Chu, DF
Gu, JK [1 ]
Liu, WH
Fawcett, JP
Dong, QG
机构
[1] Jilin Univ, Res Ctr Drug Metab, Changchun 130023, Peoples R China
[2] Yantai Univ, Sch Pharm, Yantai 264003, Peoples R China
[3] Univ Otago, Sch Pharm, Dunedin, New Zealand
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 795卷 / 02期
基金
中国国家自然科学基金;
关键词
5-fluorouracil; tegafur;
D O I
10.1016/S1570-0232(03)00571-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of 5-fluorouracil (5-FU) and its prodrug, tegafur (TF), in dog plasma. 5-FU, the internal standard, 5-bromouracil, and TF were separated on a C-18 Spherisorb ODS, column using isocratic elution with retention times of 4.4, 8.0 and 21.2 min, respectively. Detection by UV absorption at 260 nm gave a limit of quantitation of 4 mug/l for 5-FU in plasma. Calibration curves for 5-FU and TF were linear over the ranges of 4-160 mug/l and 0.48-19.2 mg/l, respectively. Intra- and inter-day precision over these concentration ranges were < 10.9 and < 13.6% for 5-FU and TF, respectively, with good accuracy for both compounds. The method was successfully applied to define plasma concentration-time curves of TF and 5-FU in dogs administered a single oral dose containing TF (100 mg) and uracil (224 mg). (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 13 条
[1]  
BENVENUTO JA, 1978, CANCER RES, V38, P3867
[2]  
CAO S, 1995, CANCER RES, V55, P6227
[3]   A REVIEW OF THE UNITED-STATES CLINICAL-EXPERIENCE OF THE FLUOROPYRIMIDINE, FTORAFUR (NSC-148958) [J].
FRIEDMAN, MA ;
IGNOFFO, RJ .
CANCER TREATMENT REVIEWS, 1980, 7 (04) :205-213
[4]  
FUJII S, 1979, GANN, V70, P209
[5]   Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma [J].
Gamelin, E ;
BoisdronCelle, M ;
Turcant, A ;
Larra, F ;
Allain, P ;
Robert, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 695 (02) :409-416
[6]  
Gamelin EC, 1996, CANCER, V77, P441, DOI 10.1002/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO
[7]  
2-N
[8]   Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer [J].
Ho, DH ;
Covington, W ;
Brown, N ;
Lin, SN ;
Pazdur, R ;
Huo, YY ;
Creaven, PJ ;
Rustum, YM ;
Meropol, NJ ;
Lassere, Y ;
Kuritani, J ;
Hayakawa, T .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (05) :351-356
[9]   FLUORESCENCE DETERMINATION OF 5-FLUOROURACIL AND 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL IN BLOOD-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
IWAMOTO, M ;
YOSHIDA, S ;
HIROSE, S .
JOURNAL OF CHROMATOGRAPHY, 1984, 310 (01) :151-157
[10]   High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma [J].
Jarugula, VR ;
Boudinot, FD .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (01) :199-203